research VITAMIN D DEPENDENT RICKETS TYPE II (VDR-11). RESPONSE TO PROLONGED THERAPY WITH NOCTURNAL CALCIUM INFUSIONS
Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.
Search
for
Sort by
Research
570-600 / 1000+ resultsresearch Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial
ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.
research Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.
research Development and Assessment of a Polyherbal Harsinghar (Nyctanthes arbortristis Linn.) Shampoo Efficacy Against Dandruff Compared to a Medicated Commercial Product
The herbal shampoo with Harsinghar works better against dandruff than a commercial product.
research Phytochemical analysis and antibacterial activities of Avicennia marina (Forssk.) Vierh. extracts against Vancomycin-resistant Enterococcus faecium
Avicennia marina leaf extract can fight Vancomycin-resistant bacteria.
research EFFICACY AND SAFETY OF STANDARDIZED CINNAMON BARK EXTRACT FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED WEIGHT LOSS AND ALOPECIA IN PATIENTS WITH BREAST CANCER: A RANDOMIZED, DOUBLE-BLIND, AND PLACEBO-CONTROLLED STUDY
Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.
research An Ayurvedic management of PCOD: A Review
Polycystic Ovarian Syndrome (PCOS) can be effectively treated with Ayurvedic dietary management.
research Viremia and viruria of trichodysplasia spinulosa‐associated polyomavirus before the development of clinical disease in a kidney transplant recipient
The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.
research 572 Development of immunotherapies targeting TCR-Vβ2 for treatment of cutaneous T cell lymphoma
Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.
research An Effective Siddha Management For Alopecia Areata (Puzhuvettu) – A Case Report
Siddha medicine can effectively treat Alopecia areata, leading to significant hair regrowth.
research Efficacy of Compound GV-350 with Tricofer® Iron, Cystine and Biotin in the Management of Telogen Effluvium in Women with Iron Deficiency
GV-350 improves hair growth and quality of life in iron-deficient women without side effects.
research Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.
research Rightly Said Hair Heat Disease!
Hair Heat Disease is caused by wet, oily hair and friction in hot, humid conditions.
research The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.
research Vesicular Carriers for Improved Oral Anticoagulation Competence of Rivaroxaban: In Vitro and In Vivo Investigation
Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.
research Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege
A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.
research Pharmacological activities of Eclipta alba (L.) Hassk. (Bhringaraja): A Review
Eclipta alba (Bhringaraja) has many medicinal uses, including protecting the liver, promoting hair growth, and reducing inflammation.
research An eruption of numerous spiny papules in a pediatric transplant patient
Early recognition and treatment of VATS in transplant patients improve outcomes.
research Systemic tofacitinib in paediatric alopecia areata
research Prevalence of tinea capitis and asymptomatic carriage amongst school going children
Tinea capitis affected 4.3% of school children, mostly boys, with T. violaceum as the main cause.
research Iodoterapia e seus Efeitos Colaterais no Tratamento de Neoplasia de Tireoide
Iodotherapy for thyroid cancer can cause dry mouth, taste loss, infections, and hair loss, so report side effects to doctors.
research PHYTOCHEMICAL PROFILE AND PHARMACOLOGICAL ACTIVITIES WITH COSMETOLOGICAL AND EMERGING APPLICATIONS OF CLITORIA TERNATEA (SANGU POO)
Clitoria ternatea has potential health and skincare benefits but needs more testing for safe use.
research Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
Baricitinib effectively regrows hair in severe alopecia areata cases.
research Uji Iritasi dan Aktivitas Penumbuh Rambut Hair Tonic dari Tanaman Usada Bali pada Mencit
The hair tonic from Usada Bali plants increased hair growth without irritating the skin.
research Artikel Pemanfaatan Lidah Mertua Sebagai Hair Tonic Untuk Perawatan Rambut Rontok
Using senseviera as a hair tonic can significantly reduce hair loss.
research Clinicoepidemiological and mycological study of tinea capitis: A study from a tertiary care centre
The grey patch variant of tinea capitis is most common, mainly spread through family and animals.
research Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy
Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.
research Efficacité à long terme du baricitinib dans le traitement de la pelade : résultats à la semaine 104 des études BRAVE-AA1 et BRAVE-AA2
Baricitinib effectively treats severe alopecia for up to 104 weeks.
research Tamoxifen-induced androgenetic alopecia in a dialysis patient with sclerosing encapsulating peritonitis (SEP)
research The Identity of Flavin with the Cataract-Preventive Factor
Flavin prevents cataracts in young rats.